According to the company, the AccuVax Vaccine Management System streamlines vaccine workflow, saves nursing time, minimizes vaccine waste, safeguards vaccine potency, and helps protect against medical errors.
Vaccines are one of the most significant public health successes. Yet, lapses in handling can render a vaccine ineffective and may leave people unprotected or needing revaccination, according to the Centers for Disease Control and Prevention.
Inventory losses due to power failure, improper storage and expired doses are common, and have created challenges for even the most advanced practices and health systems.
According to the company, AccuVax offers key advantages over conventional vaccine refrigeration and storage practices.
The system automates time-consuming storage, handling, and documentation tasks. It also dramatically simplifies compliance with CDC guidelines, as well as the requirements of the federally funded vaccine program.
AccuVax is the purpose-built vaccine supply management system that automates product control and integrity, minimises risks of incorrect vaccine delivery, and optimises office work flow so that providers can focus on care delivery.
It is an integrated solution that includes hardware, software, online access, software updates, training, optional integrations, technical support and maintenance.
TruMed Systems, a medical technology company developing innovative point-of-care supply management systems for healthcare professionals.
Merck launches Phase 3 trial for dengue vaccine candidate V181
BioNet and Bio Farma sign MoU on TdaP vaccine
Dx&Vx accelerates universal COVID-19 vaccine development
Moderna withdraws application for flu-COVID combination vaccine pending additional efficacy data
CTP delivers 18,000 sqm Serbian facility for SCHOTT Pharma to support global expansion
LakeShore Biopharma launches novel packaging solution for YSJA rabies vaccine (Vero cell)
Scancell partners with NHS Cancer Vaccine Launch Pad to accelerate melanoma trial recruitment
Orexo reports positive results for powder-based intranasal vaccine using AmorphOX technology
GC Biopharma's BARYTHRAX receives Korean regulatory approval
GSK grants USD2m to boost adult vaccination efforts
Valneva and LimmaTech begin Phase 2 infant trial for Shigella vaccine candidate S4V2
Circio Holding and Entos Pharmaceuticals collaborate on circular RNA delivery
AKAGERA Medicines completes first cohort in phase 1 SAD/MAD study of AKG-100